Latest Articles
- Hyperglycemic crises in adults: A look at the 2024 consensus report
A new report introduces revised criteria for the diagnosis of diabetic ketoacidosis and hyperglycemic hyperosmolar state, as well as new recommendations for assessment, management, and prevention of these disorders.
- All sulfa drugs are not created equal
Misinformation about “sulfa allergy” can result in unnecessary avoidance of useful medications and the prescription of less effective alternatives.
- Sarcoidosis with diffuse purplish erythematous plaques on the hands
A 70-year-old woman presented in winter with a 1-month history of asymptomatic redness of the hands.
- Psychedelic-assisted therapy: An overview for the internist
The authors review the potential effects, risks, and therapeutic applications of the psychedelic drugs MDMA (Ecstasy) and psilocybin, with a focus on MDMA-assisted therapy for posttraumatic stress disorder and psilocybin-assisted therapy for depression.
Coronary artery bypass grafting: Practice trends and projectionsFuture directions include expanding the use of multiarterial grafting, offering patients less-invasive approaches, and enhancing operative recovery.
- Can my patient with a ‘sulfa allergy’ receive celecoxib or other nonantimicrobial sulfonamides?
There is no cross-reactivity between antimicrobial and nonantimicrobial sulfonamides, and patients with a history of immunoglobulin E–mediated reaction to a sulfonamide antibiotic can receive nonantimicrobial sulfonamides.